KELOWNA, BC / ACCESSWIRE / October 16, 2024 / Lexaria Bioscience Corp. (Nasdaq:LEXX; LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, today announced that it has ...
Parcel Health®, the award-winning leader in sustainable pharmaceutical packaging, announces the launch of Tully Tubeâ„¢, the ...
NEW YORK, NY / ACCESSWIRE / October 16, 2024 / The Vets, the leading provider of at-home veterinary care, and BetterVet, a ...
NEW YORK, NY / ACCESSWIRE / October 16, 2024 / Dental bridges are a common procedure for replacing damaged, decayed, or missing teeth. The dentist removes some enamel from two teeth and then places ...
Empowering Radiologists to Grow, Work, and Live - In BalanceGREENVILLE, SC / ACCESSWIRE / October 16, 2024 / As the demand for medical imaging surges and the mandates for clinical confidence become ...
Peer-reviewed study published in NEJM Catalyst demonstrates Waymark's early intervention model significantly improved clinical outcomes for patients receiving Medicaid in Washington and VirginiaSAN ...
HACKENSACK, NJ / ACCESSWIRE / October 16, 2024 / Champions Oncology, Inc. (Nasdaq:CSBR), a leader in the development of advanced preclinical oncology solutions, is pleased to announce a licensing ...
Paige to participate with PathPresenter at Pathology Visions preconference workshopMONTVILLE, NJ / ACCESSWIRE / October 16, 2024 / PathPresenter, a comprehensive enterprise pathology workflow platform ...
InfectoSynovia is being developed to provide a high-accuracy bedside test that can diagnose PJI in less than five minutesIt is based on InfectoTest’s ability to detect the infection in tiny quantities ...
Studies from OPERA and Trio cohorts provide further real-world evidence supporting CAB LA for PrEP’s high effectiveness and adherence in preventing HIV acquisition Patient-reported results for CAB LA ...
BeneStream simplifies the complexities of public healthcare programs for users, adding even more expert help for the uninsured.DUBUQUE, IA / ACCESSWIRE / October 16, 2024 / ful. CashPay is excited to ...
Application supported by positive results from pivotal phase III EAGLE-2 and EAGLE-3 trials26 March 2025 assigned as action date for FDA decisionGepotidacin could be the first in a new class of oral ...